BRIEF-Ultragenyx Pharmaceutical Inc Says 2025 Revenue Guidance $640 Mln-$670 Mln

Reuters
13 Jan
BRIEF-<a href="https://laohu8.com/S/RARE">Ultragenyx Pharmaceutical Inc</a> Says 2025 Revenue Guidance $640 Mln-$670 Mln

Jan 12 (Reuters) - Ultragenyx Pharmaceutical Inc RARE.O:

  • ULTRAGENYX PHARMACEUTICAL INC - 2025 REVENUE GUIDANCE $640M-$670M

  • ULTRAGENYX PHARMACEUTICAL INC - PRELIMINARY 2024 TOTAL REVENUE OF $555 MILLION TO $560 MILLION, EXCEEDING TOP END OF GUIDANCE

Source text: ID:nGNX3rSf1M

Further company coverage: RARE.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10